News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Thermo Scientific has unveiled an ultra high-performance liquid chromatography (UHPLC) system so labs can process more samples and produce results to meet stricter regulations.
In a rare move for the UK’s MHRA (Medicines and Healthcare products Regulatory Agency), the regulator has helped to “future-proof” CMO Fujifilm Diosynth Biotechnologies’ mammalian cell culture manufacturing facility in Billingham, UK against potential...
A £10bn ‘mega-fund’ being considered by London Mayor Boris Johnson to boost drug development would be roughly equivalent to what it costs to develop six new medicines based on the latest industry estimates.
TxCell will enhance operator training and dedicate more resources to quality monitoring at the cell therapy facility where it halted production this week.